USA | FDA Issues Draft Guidance on Patient Focused Drug Development Gallery USA | FDA Issues Draft Guidance on Patient Focused Drug Development 2022, June 2022, Members-Only, Moderate Update, Patient Voice, RWD to Support Reg Decisions, USA USA | FDA Issues Draft Guidance on Patient Focused Drug Development Please login to view this page. USA | FDA Issues Draft Guidance on Patient Focused Drug Developmentstuart.mccully2022-08-07T16:28:02+00:00
